Rhee Sang Youl, Kim Hyun Jin, Ko Seung-Hyun, Hur Kyu Yeon, Kim Nan-Hee, Moon Min Kyong, Park Seok-O, Lee Byung-Wan, Choi Kyung Mook, Kim Jin Hwa
Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
Korean J Intern Med. 2017 Nov;32(6):959-966. doi: 10.3904/kjim.2017.312. Epub 2017 Oct 23.
In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.
为了提高生活质量并预防与糖尿病相关的慢性并发症,从2型糖尿病(T2DM)诊断的早期阶段起就需要强化生活方式改变和适当用药。在为糖尿病患者使用首种药物时,应考虑患者的临床特征、药物疗效、副作用和成本来选择合适的治疗方法。一般而言,推荐使用二甲双胍作为口服降糖单药治疗的首种药物,因为其具有出色的降血糖效果、相对较低的副作用、长期证实的安全性、低血糖风险低以及体重增加少。如果二甲双胍难以用作一线治疗,应根据临床情况选择其他合适的药物。如果单药治疗未达到血糖控制目标,应立即启动具有不同作用机制的联合治疗。